Use access key #2 to skip to page content.
  • S&P 500: 1,091.38
  • Change: -0.32%
$41.53 0.06 (0.14%)
11/20/2009 4:02 PM

GlaxoSmithKline plc (ADR) (GSK)

CAPS Rating:
*****

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating GSK

Add Stock to Watchlist

GlaxoSmithKline plc (ADR) At A Glance

Current Price: $41.53
Last Trade Time: 11/20/2009 4:02 PM
Open: $40.95
Previous Close: $41.47
Daily Range: $40.94 - $41.56
52-Week Range: $27.15 - $42.18
Volume: 1,164,239
Market Cap: $117.56B
P/E Ratio: 10.72
Compare Our Special Broker Offers!

Stock Trends

GSK VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

3

GlaxoSmithKline plc (ADR) (GSK)

Avatar RNewBuff (< 20) Submitted: 8/03/09 2:10 PM

Sirtrius a GSK subsidiary has two drugs coming through clinical trials. If they are as effective against type II diabetes as expected you can expect GSK to add billions to it's bottom line over the next 5 years.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

GlaxoSmithKline plc (ADR) (GSK)

Avatar TyrVsGarm (36.50) Submitted: 7/06/09 2:21 PM

GlaxoSmithKline has two blockbusters coming off patent in 2010 which will affect the bottom line in the near-term. While GSK has a healthy pipeline, it also is sitting on over $10 Billion worth of currency (most of it in dollars). I suspect that it will try to put some (or all) of this cash to wor...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 208 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (GSK)

Avatar richardrogers4 (64.75) Submitted: 11/14/09 2:55 AM : Outperform Start Price: $41.71 GSK Score: 0.43

Defensive picl

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar garrodcm (44.83) Submitted: 11/02/09 10:24 AM : Outperform Start Price: $40.31 GSK Score: -1.30

Good products

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar astroboy356 (63.36) Submitted: 10/16/09 5:40 PM : Outperform Start Price: $40.71 GSK Score: 0.55

Do not invest in this company they are bad bad people.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar frtedcrilly (32.64) Submitted: 10/07/09 3:39 PM : Outperform Start Price: $38.84 GSK Score: 3.40

Aaaah, aaaagh, aaaaaaaagh-choo!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GSK)

Avatar scorpionclone (61.77) Submitted: 9/18/09 10:32 PM : Outperform Start Price: $38.53 GSK Score: 4.45

obama

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 208 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 12 of 12  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJimCramer 36.31 05/29/09 Underperform 3W $32.91+26.20%+19.50%-6.69
TrackCreditSuiss 90.95 03/17/09 Outperform NS $27.89+48.91%+46.46%+2.45
TrackTobinSmith < 20 03/06/09 Outperform 1Y $27.69+50.00%+61.59%-11.59
TrackBillNygren 91.99 06/19/08 Outperform 5Y $40.80+1.78%-15.39%+17.17 Toggle the visibility of 60-Second Pitch and replies
TrackBerkowitz 82.69 05/27/08 Outperform 1Y $40.61+2.27%-17.65%+19.92 Toggle the visibility of 60-Second Pitch and replies
TrackJohnKeeley < 20 09/30/07 Outperform NS $47.61-12.77%-24.86%+12.08 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 88.49 09/30/07 Outperform NS $47.61-12.77%-24.86%+12.08 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $47.61-12.77%-24.86%+12.08 Toggle the visibility of 60-Second Pitch and replies
TrackNWQ < 20 09/30/07 Outperform NS $47.61-12.77%-24.86%+12.08 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 98.46 09/30/07 Outperform NS $47.61-12.77%-24.86%+12.08 Toggle the visibility of 60-Second Pitch and replies
TrackBearStearns 81.70 07/25/07 Underperform NS $47.16-11.94%-24.22%-12.28
TrackJPMorgan 73.67 03/22/07 Underperform NS $48.83-14.94%-19.37%-4.43

Results 1 - 12 of 12  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 812ms